RSRajeshwari Subramaniam

Rajeshwari Subramaniam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rajeshwari Subramaniam has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating the Role of Serum Beta-D-glucan Testing in Safely Reducing Antifungal Therapy in Critically Ill Patients: A Retrospective Study

    by Rajeshwari Subramaniam, Aayush Chawla, Narayanan Sarat, Ripenmeet Salhotra, Debasish Biswal, Sandeep Mangla, Pranjal Gupta

    The role of (1→3)-β-D-glucan (BDG) testing in guiding antifungal therapy (AFT) in critically ill patients remains unclear. While BDG has a high negative predictive value (NPV), is it safe to withhold AFT in critically ill BDG-negative patients has not been well studied. This retrospective cohort study analyzed BDG-negative intensive care unit (ICU) patients (p = 0.008). Antifungal therapy recipients had higher sequential organ failure assessment (SOFA) scores (9.7 ± 3.46 vs 7.4 ± 3.15, p = 0.014), indicating greater illness severity. Proven invasive candidiasis was rare (3.77%), with both cases due to Candida auris (p = 0.168). After PSM, survival differences were no longer significant (p = 0.246). Logistic regression confirmed AFT was not an independent predictor of survival [odds ratio (OR): 0.363, p = 0.156]. Withholding AFT in BDG-negative critically ill patients did not impact ICU survival, supporting BDG's role in antifungal stewardship. However, its limitations in detecting Candida auris warrant further prospective studies. Salhotra R, Biswal D, Sarat N, Chawla A, Mangla S, Gupta P, et al. Evaluating the Role of Serum Beta-D-glucan Testing in Safely Reducing Antifungal Therapy in Critically Ill Patients: A Retrospective Study. Indian J Crit Care Med 2025;29(5):413-417.


  • A Randomized Controlled Trial of Intrathecal versus Caudal Morphine-Bupivacaine on Postoperative Analgesia and Cortisol Levels in Pediatric Patients

    by Neha Pangasa, Rajeshwari Subramaniam, Gunjan Singh, Mani Kalaivani, Manpreet Kaur, Viveka P. Jyotsna, Devalina Goswami

    BACKGROUND: Morphine is commonly used in pediatric caudal blocks. We compared the analgesic efficacy and effect on cortisol levels of intrathecal morphine and bupivacaine with caudal morphine and bupivacaine in children undergoing lower abdominal surgeries. METHODS: Forty children undergoing lower abdominal surgeries were randomized to receive 4 μg/kg of intrathecal morphine and 0.5% hyperbaric bupivacaine (n = 20), or caudal morphine 40 μg/kg and 0.25% bupivacaine (n = 20). Postoperative analgesia was provided with intravenous (IV) paracetamol (PCM). The primary outcome was time to reach Face, Legs, Activity, Cry, and Consolability (FLACC) score ≥4 postoperatively. Secondary outcomes were perioperative serum cortisol levels, analgesic requirement, and parent satisfaction. RESULTS: Since seventy 5% of patients receiving intrathecal morphine and bupivacaine did not reach a FLACC score ≥4 within 24 hours, the primary outcome was presented as the Kaplan-Meier curve. The probability of FLACC score P < .001). The unadjusted and adjusted (for gender) hazard ratio (95% confidence interval [CI]) of occurrence of pain (FLACC score ≥4) was 0.07 (0.03–0.15, P < .001) and 0.06 (0.03–0.14, P < .001), respectively. The difference in means (95% CI) of cortisol levels between caudal morphine (with bupivacaine) and intrathecal morphine (with bupivacaine) groups were after intubation −0.667 (−4.99 to 3.65, P = .76), at 2 hours intraoperatively 7.88 (3.55–12.2, P < .001), 6 hours postoperatively 16.8 (12.5–21.1, P < .001), and 24 hours postoperatively 15.4 (11.1–19.7, P < .001) μg/dL. Intraoperatively, rescue fentanyl was required by 60% of patients on caudal morphine and bupivacaine against 20% of patients receiving intrathecal morphine and bupivacaine (absolute risk-reduction [95% CI] of 40% [12%–68%]; P = .010). Postoperative rescue fentanyl was required in 45% of patients on caudal morphine and bupivacaine and 5% of patients on intrathecal morphine and bupivacaine. All (100%) patients on caudal morphine and bupivacaine required postoperative PCM against 6 (30%) patients on intrathecal morphine and bupivacaine (absolute risk-reduction [95% CI] of 70% [50%–90%]; P < .001). The median (interquartile range [IQR]) parent satisfaction score for patients on caudal morphine (with bupivacaine) and intrathecal morphine (with bupivacaine) was 0(0–0) and 2(2–2) at 12 hours postoperatively (P < .001) and 0(0–1) and 2(1.5–2) at 24 hours postoperatively (P < .001). One patient in each group developed nausea and vomiting, and 1 patient in the intrathecal group developed pruritus. There was no incidence of respiratory depression. CONCLUSIONS: Intrathecal morphine and bupivacaine results in longer duration of analgesia, lower analgesic consumption, prevents surgical-stress-related elevation of serum cortisol, and improves parent satisfaction compared to caudal morphine with bupivacaine in children undergoing lower abdominal surgeries.


  • Open Access

    Comparison between opioid-based anaesthesia technique and opioid-free anaesthesia technique in patients undergoing laparotomy for gynaecological malignancy: A randomised controlled trial

    by Reshma Kalagara, Debesh Bhoi, Rajeshwari Subramaniam, Dalim Kumar Baidya, Souvik Maitra, Praveen Talawar

    Background and Aims: To investigate whether opioid-free anaesthesia (OFA) or opioid-based anaesthesia (OBA) technique with ultrasound (US)-guided rectus sheath block (RSB) provides early recovery and less opioid-related side effects in patients undergoing laparotomy for gynaecological malignancy. Methods: This was a double-blind randomised controlled trial. Fifty female patients of the American Society of Anesthesiologists (ASA) physical status I–II, aged 18–65 years, and scheduled to undergo elective gynaecological laparotomy under general anaesthesia were included. The patients were randomised into two groups. Both received US-guided RSB with 10 mL of local anaesthetic on each side. Group OBA (n = 25) received intravenous (IV) fentanyl 2 μg/kg at induction and 0.5 μg/kg as rescue analgesic. Group OFA (n = 25) received IV dexmedetomidine (0.5 μg/kg bolus over 10 min at induction, followed by 0.3 μg/kg/h infusion) and ketamine (0.25 mg/kg before incision, 0.15 mg/kg as rescue analgesic). The primary outcome was the time to attain post-anaesthesia care unit (PACU) discharge criteria. Time to eye-opening, time to extubation, time to shift to PACU, postoperative pain as visual analogue score (VAS), time to first rescue, total 24-h morphine consumption, and any postoperative nausea and vomiting till 24 h were also noted as secondary outcomes. Results: The time to attain PACU discharge criteria was comparable between the groups; however, the time to extubation and time to shift to the PACU was higher in Group OFA (P = 0.043 and P = 0.046, respectively). Other secondary outcomes were comparable (P > 0.05). Conclusion: OFA provides comparable postoperative analgesia and time to attain PACU discharge in adult patients undergoing open gynaecological oncological surgery under general anaesthesia.


  • Open Access

    Comparison of Tracheal Intubation Using the Air-Q ILA and LMA Blockbuster Among Adults Undergoing Elective Surgery: A Randomized Controlled Trial

    by Kavitha Girish, Thilaka Muthiah, Dalim Kumar Baidya, Renu Sinha, Vimi Rewari, Souvik Maitra, Manpreet Kaur, Rajeshwari Subramaniam

    Comparison of Tracheal Intubation Using the Air-Q ILA and LMA Blockbuster Among Adults Undergoing Elective Surgery: A Randomized Controlled Trial - Turkish Journal of Anaesthesiology and Reanimation


  • Open Access

    Anaesthesia for a patient of Hajdu Cheney syndrome scheduled for scoliosis surgery-A case study

    by Apoorv Chaturvedi, Rajeshwari Subramaniam, Ravindra Pandey, Sreyashi Naskar

  • Effect of incremental PEEP titration on postoperative pulmonary complications in patients undergoing emergency laparotomy: a randomized controlled trial

    by Emmanuel Easterson Ernest, Sulagna Bhattacharjee, Dalim K. Baidya, Rahul K. Anand, Bikash R. Ray, Virinder K. Bansal, Rajeshwari Subramaniam, Souvik Maitra

    Postoperative pulmonary complications (PPC) has a significant negative impact and are associated with increased length of hospital stay and cost of care. Emergency surgery is a well-established risk factor for PPC. Previous studies reported that personalized positive end-expiratory pressure (PEEP) might reduce postoperative atelectasis and postoperative pulmonary complications. N = 168 adult patients undergoing major emergency laparotomy under general anesthesia were recruited in this study. A minimum driving pressure based incremental PEEP titration was compared to a fixed PEEP of 5 cmH2O. The primary outcome was PPC up to postoperative day 7. The mean (standard deviation) of the recruited patients was 41.7(16.1)y, and 48.8% (82 of 168 patients) were female. The risk of PPC at postoperative day 7 was similar in both the study groups [Relative risk (RR) (95% Confidence interval, CI) 0.81 (0.58, 1.13); p = 0.25]. In addition, the incidence of intraoperative hypotension [p = 0.75], oxygen-free days at day 28 [p = 0.27], duration of postoperative hospital stay [p = 0.50], length of postoperative intensive care unit stay [p = 0.28], and in-hospital mortality [p = 0.38] were similar in two groups. Incidence of PPC was not reduced with the use of an individualized PEEP strategy based on lowest driving pressure. However, the incidence of hypotension and bradycardia was also not increased with titrated PEEP. Trial Registration: www.ctri.nic.in; CTRI/2020/12/029765.


  • Open Access

    Subphenotypes of SARS-CoV-2-Associated ARDS Overlap Each Other: A Retrospective Analysis

    by Parvathy R. Nair, Kavitha Girish, Gouri Mini, Tazeen Khan, Damarla Haritha, Koninica Sanyal, Sulagna Bhattacharjee, Dalim K. Baidya, Bikash R. Ray, Rahul K. Anand, et al.

    Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus-associated pneumonia and acute respiratory distress syndrome (ARDS) were often associated with hyperinflammation and elevation of several serum inflammatory markers but usually less than what is observed in non-coronavirus disease (COVID) ARDS. Elevated inflammatory markers such as C-reactive protein, interleukin (IL)-6, etc., are associated with severe infection. This study identified subphenotypes of COVID-19 ARDS patients by latent profile analysis in a cohort of Indian patients. Methods Data of n = 233 adult Indian patients with laboratory-confirmed SARS-CoV-2 infection admitted to a tertiary care teaching hospital were analyzed in this retrospective study. Only patients with acute respiratory failure (defined by partial pressure of oxygen/fraction of inspired oxygen ratio < 200 mm Hg) and chest X-ray showing bilateral infiltrates were included. Results The patients' mean (standard deviation) age was 53.3 (14.9) years, and 62% were male. A two subphenotypic model was formulated based on the lowest Bayesian information criterion. Neutrophil-to-lymphocyte ratio and serum IL-6 were latent variables in that model (entropy 0.91). The second phenotype (hyperinflammatory) had lower platelet count (p = 0.02), higher serum creatinine (p = 0.004), higher C-reactive protein (p = 0.001), higher ferritin (p < 0.001), and serum lactate dehydrogenase (p = 0.009). Age-adjusted hospital mortality (p = 0.007), duration of hospital stay (p < 0.001), and duration of intensive care unit stay (p < 0.001) were significantly higher in the second subphenotype. Conclusion Two distinct but overlapping subphenotypes were identified in SARS-CoV-2-associated respiratory failure. Hyperinflammatory subphenotype was associated with significantly poor short-term outcomes.


  • Open Access

    Comparison of Prophylactic Infusion of Phenylephrine Versus Norepinephrine for the Prevention of Post Spinal Hypotension in Parturients Undergoing Elective Caesarean Section-a Randomized, Double-Blinded, Non-Inferiority Trial

    by Banupriya Ravichandrane, Rajeshwari Subramaniam, Thilaka Muthiah, Praveen Talawar, Rajasekar Ramadurai

    Objective: Postspinal hypotension occurs in nearly 50% of women undergoing cesarean section (CS). Although phenylephrine (PE) is currently the vasopressor of choice, severe maternal bradycardia may adversely affect the fetal status due to the reduction in the maternal cardiac output. Norepinephrine (NE) is not associated with bradycardia and is now being evaluated for the treatment of post-spinal hypotension in obstetric patients. The hypothesis of this study was that the prophylactic NE infusion was non-inferior to PE infusion when used for the prevention of postspinal hypotension. Methods: This was a randomized, double-blinded controlled study conducted in 130 parturients scheduled for CS. The participants received either prophylactic NE (5 mu g min(-1)) or PE (25 mu g min(-1)) infusion beginning at the time of spinal injection. The primary outcome was the incidence of hypotension in both groups. Maternal bradycardia, reactive hypertension, nausea and vomiting, requirement of rescue boluses of vasopressor and/or atropine, and neonatal acid base status were also recorded. Results: The incidence of hypotension was 33.80% (22 of 65) in Group PE and 26.10% (17 of 65) in Group NE (P=0.85). The absolute risk difference [90% confidence interval (CI)] in the incidence of hypotension between the groups was -7.7% (-20.9, 5.4). The upper limit of the CI was less than the non-inferiority margin of 20%, indicating that the NE infusion was non-inferior to PE. Conclusion: Prophylactic infusion of NE is not inferior to prophylactic PE infusion in the prevention of postspinal hypotension in patients undergoing CS.


  • Open Access

    Textbook of Ventilation, Fluids, Electrolytes and Blood Gases

    by Subramaniam Rajeshwari


  • Open Access

    C-MAC® pediatric D-blade for intubation in a child with Hurler syndrome

    by Kanil R. Kumar, Reshma Kalagara, Rajeshwari Subramaniam, Swati Singh